Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
July 6, 2015 | ||||
Nanoliter liquid transfers with Tecan’s Freedom EVO® |
||||
Männedorf, Switzerland, July 6, 2015 – Researchers at Germany's University of Konstanz have established an innovative technique to allow more cost-effective screening of small molecules. Using the Freedom EVO® workstation’s MultiChannel Arm™ 384, the University’s Screening Center has achieved reliable liquid transfers down to just 80 nanoliters. Silke Müller, a biologist in the screening facility, explained: “We work with a wide range of samples – enzymes, mammalian cells, bacteria – using various high throughput screening assay formats according to the needs of individual research groups. Our Freedom EVO therefore needs to be very flexible in the types of assays we can perform.” |
||||
For more information please contact Tecan Trading AG Tel +41 (0)44 922 81 11
About Tecan Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics. The company specializes in the development, production and distribution of automated workflow solutions for laboratories in the life sciences sector. Its clients include pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. As an original equipment manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2014, Tecan generated sales of CHF 400 million (USD 437 million; EUR 331 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TECN; ISIN CH0012100191). |